 | • レポートコード：MRC2-11QY04577 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、98ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は自己管理薬のグローバル市場について調査・分析したレポートです。種類別（経口、皮下、経鼻、経皮、その他）市場規模、用途別（病院薬局、小売薬局、オンライン薬局）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別自己管理薬の競争状況、市場シェア ・世界の自己管理薬市場：種類別市場規模 2015年-2020年（経口、皮下、経鼻、経皮、その他） ・世界の自己管理薬市場：種類別市場規模予測 2021年-2026年（経口、皮下、経鼻、経皮、その他） ・世界の自己管理薬市場：用途別市場規模 2015年-2020年（病院薬局、小売薬局、オンライン薬局） ・世界の自己管理薬市場：用途別市場規模予測 2021年-2026年（病院薬局、小売薬局、オンライン薬局） ・北米の自己管理薬市場分析：米国、カナダ ・ヨーロッパの自己管理薬市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの自己管理薬市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の自己管理薬市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの自己管理薬市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Pfizer、Abbott Laboratories、Novartis、Sanofi、BD、Takeda Pharmaceutical、Mylan、Amgen、Antares Pharma、Purdue Pharma ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Self-administration is, in its medical sense, the process of a subject administering a pharmacological substance to themself. A clinical example of this is the subcutaneous “self-injection” of insulin by a diabetic patient.
By distribution channel, the hospital pharmacies segment is expected to represent significant revenue growth by the end of 2025. However, the online pharmacies distribution channel segment is expected to register a healthy CAGR during the forecast period.
Market Analysis and Insights: Global Self-Administered Medication Market
The global Self-Administered Medication market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Self-Administered Medication Scope and Market Size
Self-Administered Medication market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Self-Administered Medication market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Pfizer
Abbott Laboratories
Novartis
Sanofi
BD
Takeda Pharmaceutical
Mylan
Amgen
Antares Pharma
Purdue Pharma
Market segment by Type, the product can be split into
Oral
Subcutaneous
Nasal
Transdermal
Others
Market segment by Application, split into
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Self-Administered Medication Revenue
1.4 Market by Type
1.4.1 Global Self-Administered Medication Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Oral
1.4.3 Subcutaneous
1.4.4 Nasal
1.4.5 Transdermal
1.4.6 Others
1.5 Market by Application
1.5.1 Global Self-Administered Medication Market Share by Application: 2020 VS 2026
1.5.2 Hospital Pharmacies
1.5.3 Retail Pharmacies
1.5.4 Online Pharmacies
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Self-Administered Medication Market Perspective (2015-2026)
2.2 Global Self-Administered Medication Growth Trends by Regions
2.2.1 Self-Administered Medication Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Self-Administered Medication Historic Market Share by Regions (2015-2020)
2.2.3 Self-Administered Medication Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Self-Administered Medication Market Growth Strategy
2.3.6 Primary Interviews with Key Self-Administered Medication Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Self-Administered Medication Players by Market Size
3.1.1 Global Top Self-Administered Medication Players by Revenue (2015-2020)
3.1.2 Global Self-Administered Medication Revenue Market Share by Players (2015-2020)
3.1.3 Global Self-Administered Medication Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Self-Administered Medication Market Concentration Ratio
3.2.1 Global Self-Administered Medication Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Self-Administered Medication Revenue in 2019
3.3 Self-Administered Medication Key Players Head office and Area Served
3.4 Key Players Self-Administered Medication Product Solution and Service
3.5 Date of Enter into Self-Administered Medication Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Self-Administered Medication Historic Market Size by Type (2015-2020)
4.2 Global Self-Administered Medication Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Self-Administered Medication Market Size by Application (2015-2020)
5.2 Global Self-Administered Medication Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Self-Administered Medication Market Size (2015-2020)
6.2 Self-Administered Medication Key Players in North America (2019-2020)
6.3 North America Self-Administered Medication Market Size by Type (2015-2020)
6.4 North America Self-Administered Medication Market Size by Application (2015-2020)
7 Europe
7.1 Europe Self-Administered Medication Market Size (2015-2020)
7.2 Self-Administered Medication Key Players in Europe (2019-2020)
7.3 Europe Self-Administered Medication Market Size by Type (2015-2020)
7.4 Europe Self-Administered Medication Market Size by Application (2015-2020)
8 China
8.1 China Self-Administered Medication Market Size (2015-2020)
8.2 Self-Administered Medication Key Players in China (2019-2020)
8.3 China Self-Administered Medication Market Size by Type (2015-2020)
8.4 China Self-Administered Medication Market Size by Application (2015-2020)
9 Japan
9.1 Japan Self-Administered Medication Market Size (2015-2020)
9.2 Self-Administered Medication Key Players in Japan (2019-2020)
9.3 Japan Self-Administered Medication Market Size by Type (2015-2020)
9.4 Japan Self-Administered Medication Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Self-Administered Medication Market Size (2015-2020)
10.2 Self-Administered Medication Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Self-Administered Medication Market Size by Type (2015-2020)
10.4 Southeast Asia Self-Administered Medication Market Size by Application (2015-2020)
11 India
11.1 India Self-Administered Medication Market Size (2015-2020)
11.2 Self-Administered Medication Key Players in India (2019-2020)
11.3 India Self-Administered Medication Market Size by Type (2015-2020)
11.4 India Self-Administered Medication Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Self-Administered Medication Market Size (2015-2020)
12.2 Self-Administered Medication Key Players in Central & South America (2019-2020)
12.3 Central & South America Self-Administered Medication Market Size by Type (2015-2020)
12.4 Central & South America Self-Administered Medication Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Pfizer
13.1.1 Pfizer Company Details
13.1.2 Pfizer Business Overview
13.1.3 Pfizer Self-Administered Medication Introduction
13.1.4 Pfizer Revenue in Self-Administered Medication Business (2015-2020))
13.1.5 Pfizer Recent Development
13.2 Abbott Laboratories
13.2.1 Abbott Laboratories Company Details
13.2.2 Abbott Laboratories Business Overview
13.2.3 Abbott Laboratories Self-Administered Medication Introduction
13.2.4 Abbott Laboratories Revenue in Self-Administered Medication Business (2015-2020)
13.2.5 Abbott Laboratories Recent Development
13.3 Novartis
13.3.1 Novartis Company Details
13.3.2 Novartis Business Overview
13.3.3 Novartis Self-Administered Medication Introduction
13.3.4 Novartis Revenue in Self-Administered Medication Business (2015-2020)
13.3.5 Novartis Recent Development
13.4 Sanofi
13.4.1 Sanofi Company Details
13.4.2 Sanofi Business Overview
13.4.3 Sanofi Self-Administered Medication Introduction
13.4.4 Sanofi Revenue in Self-Administered Medication Business (2015-2020)
13.4.5 Sanofi Recent Development
13.5 BD
13.5.1 BD Company Details
13.5.2 BD Business Overview
13.5.3 BD Self-Administered Medication Introduction
13.5.4 BD Revenue in Self-Administered Medication Business (2015-2020)
13.5.5 BD Recent Development
13.6 Takeda Pharmaceutical
13.6.1 Takeda Pharmaceutical Company Details
13.6.2 Takeda Pharmaceutical Business Overview
13.6.3 Takeda Pharmaceutical Self-Administered Medication Introduction
13.6.4 Takeda Pharmaceutical Revenue in Self-Administered Medication Business (2015-2020)
13.6.5 Takeda Pharmaceutical Recent Development
13.7 Mylan
13.7.1 Mylan Company Details
13.7.2 Mylan Business Overview
13.7.3 Mylan Self-Administered Medication Introduction
13.7.4 Mylan Revenue in Self-Administered Medication Business (2015-2020)
13.7.5 Mylan Recent Development
13.8 Amgen
13.8.1 Amgen Company Details
13.8.2 Amgen Business Overview
13.8.3 Amgen Self-Administered Medication Introduction
13.8.4 Amgen Revenue in Self-Administered Medication Business (2015-2020)
13.8.5 Amgen Recent Development
13.9 Antares Pharma
13.9.1 Antares Pharma Company Details
13.9.2 Antares Pharma Business Overview
13.9.3 Antares Pharma Self-Administered Medication Introduction
13.9.4 Antares Pharma Revenue in Self-Administered Medication Business (2015-2020)
13.9.5 Antares Pharma Recent Development
13.10 Purdue Pharma
13.10.1 Purdue Pharma Company Details
13.10.2 Purdue Pharma Business Overview
13.10.3 Purdue Pharma Self-Administered Medication Introduction
13.10.4 Purdue Pharma Revenue in Self-Administered Medication Business (2015-2020)
13.10.5 Purdue Pharma Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Self-Administered Medication Key Market Segments
Table 2. Key Players Covered: Ranking by Self-Administered Medication Revenue
Table 3. Ranking of Global Top Self-Administered Medication Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Self-Administered Medication Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Oral
Table 6. Key Players of Subcutaneous
Table 7. Key Players of Nasal
Table 8. Key Players of Transdermal
Table 9. Key Players of Others
Table 10. Global Self-Administered Medication Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 11. Global Self-Administered Medication Market Size by Regions (US$ Million): 2020 VS 2026
Table 12. Global Self-Administered Medication Market Size by Regions (2015-2020) (US$ Million)
Table 13. Global Self-Administered Medication Market Share by Regions (2015-2020)
Table 14. Global Self-Administered Medication Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 15. Global Self-Administered Medication Market Share by Regions (2021-2026)
Table 16. Market Top Trends
Table 17. Key Drivers: Impact Analysis
Table 18. Key Challenges
Table 19. Self-Administered Medication Market Growth Strategy
Table 20. Main Points Interviewed from Key Self-Administered Medication Players
Table 21. Global Self-Administered Medication Revenue by Players (2015-2020) (Million US$)
Table 22. Global Self-Administered Medication Market Share by Players (2015-2020)
Table 23. Global Top Self-Administered Medication Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Self-Administered Medication as of 2019)
Table 24. Global Self-Administered Medication by Players Market Concentration Ratio (CR5 and HHI)
Table 25. Key Players Headquarters and Area Served
Table 26. Key Players Self-Administered Medication Product Solution and Service
Table 27. Date of Enter into Self-Administered Medication Market
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Self-Administered Medication Market Size by Type (2015-2020) (Million US$)
Table 30. Global Self-Administered Medication Market Size Share by Type (2015-2020)
Table 31. Global Self-Administered Medication Revenue Market Share by Type (2021-2026)
Table 32. Global Self-Administered Medication Market Size Share by Application (2015-2020)
Table 33. Global Self-Administered Medication Market Size by Application (2015-2020) (Million US$)
Table 34. Global Self-Administered Medication Market Size Share by Application (2021-2026)
Table 35. North America Key Players Self-Administered Medication Revenue (2019-2020) (Million US$)
Table 36. North America Key Players Self-Administered Medication Market Share (2019-2020)
Table 37. North America Self-Administered Medication Market Size by Type (2015-2020) (Million US$)
Table 38. North America Self-Administered Medication Market Share by Type (2015-2020)
Table 39. North America Self-Administered Medication Market Size by Application (2015-2020) (Million US$)
Table 40. North America Self-Administered Medication Market Share by Application (2015-2020)
Table 41. Europe Key Players Self-Administered Medication Revenue (2019-2020) (Million US$)
Table 42. Europe Key Players Self-Administered Medication Market Share (2019-2020)
Table 43. Europe Self-Administered Medication Market Size by Type (2015-2020) (Million US$)
Table 44. Europe Self-Administered Medication Market Share by Type (2015-2020)
Table 45. Europe Self-Administered Medication Market Size by Application (2015-2020) (Million US$)
Table 46. Europe Self-Administered Medication Market Share by Application (2015-2020)
Table 47. China Key Players Self-Administered Medication Revenue (2019-2020) (Million US$)
Table 48. China Key Players Self-Administered Medication Market Share (2019-2020)
Table 49. China Self-Administered Medication Market Size by Type (2015-2020) (Million US$)
Table 50. China Self-Administered Medication Market Share by Type (2015-2020)
Table 51. China Self-Administered Medication Market Size by Application (2015-2020) (Million US$)
Table 52. China Self-Administered Medication Market Share by Application (2015-2020)
Table 53. Japan Key Players Self-Administered Medication Revenue (2019-2020) (Million US$)
Table 54. Japan Key Players Self-Administered Medication Market Share (2019-2020)
Table 55. Japan Self-Administered Medication Market Size by Type (2015-2020) (Million US$)
Table 56. Japan Self-Administered Medication Market Share by Type (2015-2020)
Table 57. Japan Self-Administered Medication Market Size by Application (2015-2020) (Million US$)
Table 58. Japan Self-Administered Medication Market Share by Application (2015-2020)
Table 59. Southeast Asia Key Players Self-Administered Medication Revenue (2019-2020) (Million US$)
Table 60. Southeast Asia Key Players Self-Administered Medication Market Share (2019-2020)
Table 61. Southeast Asia Self-Administered Medication Market Size by Type (2015-2020) (Million US$)
Table 62. Southeast Asia Self-Administered Medication Market Share by Type (2015-2020)
Table 63. Southeast Asia Self-Administered Medication Market Size by Application (2015-2020) (Million US$)
Table 64. Southeast Asia Self-Administered Medication Market Share by Application (2015-2020)
Table 65. India Key Players Self-Administered Medication Revenue (2019-2020) (Million US$)
Table 66. India Key Players Self-Administered Medication Market Share (2019-2020)
Table 67. India Self-Administered Medication Market Size by Type (2015-2020) (Million US$)
Table 68. India Self-Administered Medication Market Share by Type (2015-2020)
Table 69. India Self-Administered Medication Market Size by Application (2015-2020) (Million US$)
Table 70. India Self-Administered Medication Market Share by Application (2015-2020)
Table 71. Central & South America Key Players Self-Administered Medication Revenue (2019-2020) (Million US$)
Table 72. Central & South America Key Players Self-Administered Medication Market Share (2019-2020)
Table 73. Central & South America Self-Administered Medication Market Size by Type (2015-2020) (Million US$)
Table 74. Central & South America Self-Administered Medication Market Share by Type (2015-2020)
Table 75. Central & South America Self-Administered Medication Market Size by Application (2015-2020) (Million US$)
Table 76. Central & South America Self-Administered Medication Market Share by Application (2015-2020)
Table 77. Pfizer Company Details
Table 78. Pfizer Business Overview
Table 79. Pfizer Product
Table 80. Pfizer Revenue in Self-Administered Medication Business (2015-2020) (Million US$)
Table 81. Pfizer Recent Development
Table 82. Abbott Laboratories Company Details
Table 83. Abbott Laboratories Business Overview
Table 84. Abbott Laboratories Product
Table 85. Abbott Laboratories Revenue in Self-Administered Medication Business (2015-2020) (Million US$)
Table 86. Abbott Laboratories Recent Development
Table 87. Novartis Company Details
Table 88. Novartis Business Overview
Table 89. Novartis Product
Table 90. Novartis Revenue in Self-Administered Medication Business (2015-2020) (Million US$)
Table 91. Novartis Recent Development
Table 92. Sanofi Company Details
Table 93. Sanofi Business Overview
Table 94. Sanofi Product
Table 95. Sanofi Revenue in Self-Administered Medication Business (2015-2020) (Million US$)
Table 96. Sanofi Recent Development
Table 97. BD Company Details
Table 98. BD Business Overview
Table 99. BD Product
Table 100. BD Revenue in Self-Administered Medication Business (2015-2020) (Million US$)
Table 101. BD Recent Development
Table 102. Takeda Pharmaceutical Company Details
Table 103. Takeda Pharmaceutical Business Overview
Table 104. Takeda Pharmaceutical Product
Table 105. Takeda Pharmaceutical Revenue in Self-Administered Medication Business (2015-2020) (Million US$)
Table 106. Takeda Pharmaceutical Recent Development
Table 107. Mylan Company Details
Table 108. Mylan Business Overview
Table 109. Mylan Product
Table 110. Mylan Revenue in Self-Administered Medication Business (2015-2020) (Million US$)
Table 111. Mylan Recent Development
Table 112. Amgen Business Overview
Table 113. Amgen Product
Table 114. Amgen Company Details
Table 115. Amgen Revenue in Self-Administered Medication Business (2015-2020) (Million US$)
Table 116. Amgen Recent Development
Table 117. Antares Pharma Company Details
Table 118. Antares Pharma Business Overview
Table 119. Antares Pharma Product
Table 120. Antares Pharma Revenue in Self-Administered Medication Business (2015-2020) (Million US$)
Table 121. Antares Pharma Recent Development
Table 122. Purdue Pharma Company Details
Table 123. Purdue Pharma Business Overview
Table 124. Purdue Pharma Product
Table 125. Purdue Pharma Revenue in Self-Administered Medication Business (2015-2020) (Million US$)
Table 126. Purdue Pharma Recent Development
Table 127. Research Programs/Design for This Report
Table 128. Key Data Information from Secondary Sources
Table 129. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Self-Administered Medication Market Share by Type: 2020 VS 2026
Figure 2. Oral Features
Figure 3. Subcutaneous Features
Figure 4. Nasal Features
Figure 5. Transdermal Features
Figure 6. Others Features
Figure 7. Global Self-Administered Medication Market Share by Application: 2020 VS 2026
Figure 8. Hospital Pharmacies Case Studies
Figure 9. Retail Pharmacies Case Studies
Figure 10. Online Pharmacies Case Studies
Figure 11. Self-Administered Medication Report Years Considered
Figure 12. Global Self-Administered Medication Market Size YoY Growth 2015-2026 (US$ Million)
Figure 13. Global Self-Administered Medication Market Share by Regions: 2020 VS 2026
Figure 14. Global Self-Administered Medication Market Share by Regions (2021-2026)
Figure 15. Porter's Five Forces Analysis
Figure 16. Global Self-Administered Medication Market Share by Players in 2019
Figure 17. Global Top Self-Administered Medication Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Self-Administered Medication as of 2019
Figure 18. The Top 10 and 5 Players Market Share by Self-Administered Medication Revenue in 2019
Figure 19. North America Self-Administered Medication Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Europe Self-Administered Medication Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. China Self-Administered Medication Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Japan Self-Administered Medication Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Southeast Asia Self-Administered Medication Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. India Self-Administered Medication Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Central & South America Self-Administered Medication Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Bottom-up and Top-down Approaches for This Report
Figure 27. Data Triangulation
Figure 28. Key Executives Interviewed
自己投与薬の世界市場（～2026年） Market Analysis and Insights: Global Self-administered Drugs Market The global Self-administered Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Self-administered Drugs Scope and Market Size Self-administered Dru…- 薬物療法管理の世界市場（～2026年） Medication therapy management, generally called medicine use review in the United kingdom, is a service provided typically by pharmacists that aims to improve outcomes by helping people to better understand their health conditions and the medications used to manage them. This includes providing educ…
- インフルエンザ治療薬の世界市場（～2026年） Influenza medication includes antiviral drugs prescribed for the treatment of influenza. Influenza, also known as flu, is a respiratory disease caused by an influenza virus. It is a viral infectious disease that includes three major types: type A, type B, and type C. The common symptoms of the disor…
- 抗マラリア薬の世界市場（～2026年） Malaria is a life-threatening disease caused by parasites which are transmitted to people through the bite of an infected female anopheles mosquitoes. This disease is preventable and curable. Humans are infected by four recognized species of malarial parasites, namely, Plasmodium falciparum, P. viva…
- ペット用医薬品の世界市場（～2026年） Market Analysis and Insights: Global Pet Medication Market The global Pet Medication market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Pet Medication Scope and Market Size Pet Medication market is segmented by Type, and …